Join us for a practical, founder‑friendly deep dive into today’s investment landscape. Our speakers will cover the full spectrum of early‑stage financing tools (SAFEs, convertible notes, priced rounds), unpack term sheets, discuss ownership preservation, and explore current trends shaping the market. This interactive session will be built around your questions and real‑world scenarios.
About the Speakers:
Stephen Thau is a Partner in Orrick’s Technology Companies Group and a Co-Chair of the Life Sciences & HealthTech Group. He advises life sciences, medical device, health IT, and technology companies on financing, licensing and strategic collaborations, mergers and acquisitions, and other key growth milestones, and also represents venture capital firms in financing transactions. Stephen has been recognized as a Leading Life Sciences Lawyer by LMG Life Sciences and shortlisted as Venture Capital Attorney of the Year.
Gregg Griner is a Partner in Orrick’s Technology Companies Group and Co-Leader of the firm’s Chicago office. He advises companies at every stage of growth—from startups to public companies—on corporate and securities matters, including public and private financings, mergers and acquisitions, venture capital fund formation, governance, and strategic transactions. Gregg has been recognized by Best Lawyers for Technology Law and by Massachusetts Lawyers Weekly as a Go-To Lawyer for Healthcare/Life Sciences.
Sonia Kim
(847) 467-0446
Email